Navigation Links
National Psoriasis Foundation awards 13 psoriasis research fellowships

PORTLAND, Ore. (July 17, 2014)Twelve residents and medical students each received a one-year, $50,000 National Psoriasis Foundation fellowship to study psoriasis. The fellowships aim to increase the number of scientists studying and treating psoriatic disease by encouraging promising doctors to dedicate their careers to the study of psoriasis as physician researchers.

The program pairs an early-career doctor with an established psoriatic disease researcher to oversee their work. Learn more about the Psoriasis Foundation fellowship program:

The National Psoriasis Foundation Medical Dermatology Fellows for 2014 are:

  • Dena Elkeeb, M.D., of University of Utah, will develop a pediatric study group within the Utah Psoriasis Initiative to assess the impact of systemic corticosteroids on physical characteristics of psoriasis, its severity and the patient's overall health.

  • Aleksandra Florek, M.D., of University of Colorado Denver, will study the epidemiology of psoriatic disease and related health risks, or comorbidities, and investigate issues related to treating psoriasis, such as cost and effectiveness.

    The National Psoriasis Foundation Amgen Medical Dermatology Fellowships, supported by a grant from Amgen, are:

  • Zelma Chiesa Fuxench, M.D., of the University Of Pennsylvania Perelman School Of Medicine, will determine risks of major cardiovascular events in people with psoriasis and whether treating with the drug Humira (adalimumab) improves vascular inflammation. She will also study the effect of certain psoriasis treatments on skin cancer risk.

  • Jessica Donigan, M.D., M.P.H., of Massachusetts General Hospital/Harvard Medical School, will evaluate why psoriasis plaques appear to be more stigmatizing than the lesions from other dermatologic diseases.

  • Rivka Friedland, M.D., of Northwestern University, will examine the safety and efficacy of systemic medications and phototherapy on psoriasis in children.

  • Dario Kivelivetch, M.D., of Baylor Research Institute, will evaluate cardiovascular risk in people with psoriasis using coronary artery calcium scores, which are special X-ray tests that can check for early-stage heart disease to determine its severity.

  • Davida Kornreich, M.D., of the Icahn School of Medicine at Mt. Sinai, will analyze whether applying topicals in different orders changes their effectiveness. Kornreich will also study the safety and effectiveness of a holistic treatment in moderate to severe plaque psoriasis.

  • Marina Li, B.S., a third-year medical student at Case Western Reserve University, will examine whether reducing skin inflammation also reduces blood clots and other signs of cardiovascular disease.

  • Forum Patel, M.D., of the University of California, Davis, will identify if complex sugars called glycans are biomarkers, or biological signs, of psoriasis.

  • Scott Santilli, M.D., of University Hospital Case Medical Center, will examine the effect of systemic, or whole-body, psoriasis therapy and its potential to regulate cardiovascular risk in people with psoriasis.

  • Aimee Two, M.D., of University of California, San Diego, will investigate the role of dendritic cells, or pro-inflammatory cells in the immune system, in psoriasis and whether hyaluronidase, an enzyme that may cause dendritic cells to move away from the skin, may be effective at stopping inflammation.

  • Shaowei Wu, M.D., Ph.D., of Brown University, will use data from two on-going national Nurses' Health Studies to investigate the relationship between pregnancy, menstruation, menopause and postmenopausal hormone use in the risk of psoriatic disease.

    Additionally, the Dr. Mark G. Lebwohl Medical Dermatology Fellowship recipient, named to recognize Dr. Mark Lebwohl, chairman emeritus of the National Psoriasis Foundation Medical Board and one of the world's leading psoriasis experts, is:

  • Emily Osier, M.D., of Rady Children's Hospital, University of California, San Diego, who will develop screening guidelines for comorbidities, or associated health risks, in children with psoriasis.


  • Contact: Noe Baker
    National Psoriasis Foundation

    Related medicine news :

    1. Huntsman Cancer Institute receives NIH grant to establish national clinical trials site
    2. Sharon Kleyne Hour Power of Water Announces International Water Conference in Bulgaria
    3. Real Madrid vs. Inter Milan Tickets in Berkeley, CA: Ticket Down Slashes Prices on Guinness International Champions Cup Tickets at California Stadium
    4. Maryland Laser Skin and Vein to Volunteer at National LPGA Events
    5. Ventura All on Four Procedure Expert Speaking at International Conference Today
    6. My IDentity Doctor Soon to Launch a New Website and to Offer Engraved Medical Bracelets in Other International Languages
    7. DynaMed™ Joins with Guideline International Network to Improve the Quality of Healthcare
    8. 1st Annual Team UA Next Campaign Launches National Search for Elite Under Armour Youth Athletes
    9. Think Twice About Tattoos on National Tattoo Day
    10. Mark Soloway, MD, Internationally Recognized Leader in Urologic Oncology, Joins Memorial Cancer Institute to Start New Division
    11. Celebrate the Tattoos you Love and Clear the Ones you Regret with PicoSure® on National Tattoo Day July 17th 2014 at Park Avenue Laser Treatment by Dr. Johanna Youner
    Post Your Comments:
    (Date:6/18/2019)... , ... June 18, 2019 , ... ... addressing unmet needs in the field of urology, today announced that Aaron Berger, ... UroLift® Center of Excellence. The designation recognizes that Dr. Aaron Berger has achieved ...
    (Date:6/16/2019)... ... June 15, 2019 , ... Convoy of Hope continues to celebrate ... to helping those in need around the world. To date, Convoy has worked with ... Convoy’s work would not be possible without the dedication and generosity of churches, organizations, ...
    (Date:6/14/2019)... , ... June 14, 2019 , ... This past Saturday, ... and their dedicated support staff hosted the Parma Heights Day of Giving, where members ... about the event through local nonprofits that partnered with the Smiles for Everyone ...
    (Date:6/13/2019)... ... June 13, 2019 , ... ... Second Test (BL30SEC) has been accepted by the 2019 National Conference of Interstate ... N requirements. , The Charm BL30SEC test was validated by third party ...
    (Date:6/13/2019)... , ... June 13, 2019 , ... ... is proud to present the second annual Women|Future Conference and the ... allow attendees to better position themselves and their organizations in tomorrow's marketplace. , ...
    Breaking Medicine News(10 mins):
    (Date:6/20/2019)... ... June 20, 2019 , ... Phlexglobal today announced an important ... The guidance took effect on June 6, 2019, and promises to have far-reaching impacts ... departments and systems. , At 17 pages and going into specific detail – unusual ...
    (Date:6/19/2019)... ... June 19, 2019 , ... Mahendra Kumar Trivedi has ... Physical Properties of Biofield Treated Bile Salt and Proteose Peptone became a No. ... Medicine, Biochemistry, Medical Technology, Pathophysiology, Molecular Biology, Science Reference and 45-Minute Science and ...
    (Date:6/19/2019)... ... June 19, 2019 , ... “We sometimes take out teeth for granted,” said Arroyo Grande ... seldom think about our teeth unless it’s baby’s first tooth, that first visit from the ... and have a very important role in our overall health. Each tooth is as unique ...
    Breaking Medicine Technology: